Elinzanetant reduces severity and frequency of hot flashes and night sweats in breast cancer patients: Clinical trial

Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can occur because of the menopause or because of hormone treatment for breast cancer. Now, a new analysis of data from the trial shows that it also gives sustained relief regardless of the type of hormone treatment cancer patients receive.